...
首页> 外文期刊>Washington Drug Letter >Federal Court Revives Liability Suits Against Wyeth, GlaxoSmithKline
【24h】

Federal Court Revives Liability Suits Against Wyeth, GlaxoSmithKline

机译:联邦法院撤销对惠氏和葛兰素史克的责任诉讼

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A federal appeals court has revived two product liability suits against GlaxoSmithKline (GSK) and Wyeth in the wake of the U.S. Supreme Court's decision in Wyeth v. Levine.rnBoth lawsuits had been dismissed by U.S. District Courts on the grounds that federal law preempted failure-to-warn claims against the companies. But the U.S. Court of Appeals for the Tenth Circuit reversed those decisions and remanded the cases back to the district courts Wednesday, saying that following Wyeth v. Levine, the companies must provide clear evidence that the FDA would have rejected labeling changes had they been proposed.
机译:在美国最高法院在Wyeth诉Levine案中做出裁决后,联邦上诉法院已撤销了针对葛兰素史克(GSK)和惠氏的两项产品责任诉讼。警告对公司的索赔。但是美国第十巡回上诉法院周三推翻了这些决定,并将这些案发还给地方法院,称在惠氏诉莱文案之后,两家公司必须提供明确的证据,表明如果提出建议,FDA将拒绝标签变更。 。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号